This article is more than 5 years old. Information may no longer be current.

Intellijoint Surgical receives medical device license for hip replacement device

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Intellijoint Surgical Inc. received a Health Canada Medical Device License for the Intellijoint HIP. The device enables surgeons to quantify the key measurements needed for accurate primary and revision hip replacement.

“Receiving health Canada’s license to launch Intellijoint HIP in Canada, and our ongoing studies in Toronto Area Hospitals are exciting milestones,” Armen Bakirtzian, chief executive officer of Intellijoint, stated in a company press release. “In addition, we have met the international requirements for our quality management system for the design and manufacture of medical devices; and have submitted our application to the FDA for marketing Intellijoint HIP in the United States.”